News

News and Press Releases
About the CF Foundation | Clinical Trials | Our Research Approach Cystic Fibrosis Foundation Awards Up to $3.5M to Arrevus Inc. to Develop Treatment for Pulmonary Exacerbations

The Cystic Fibrosis Foundation awarded up to $3.5 million to Arrevus Inc. to test a potential treatment for pulmonary exacerbations in people with cystic fibrosis in a late phase clinical trial.

| 1 min read
About the CF Foundation | Our Research Approach Cystic Fibrosis Foundation Announces Investment in SalioGen Therapeutics to Fund Genetic Therapies Research

Investment will support discovery research of a novel Gene CodingTM approach that could benefit all people with CF regardless of their mutation
 

| 5 min read
About the CF Foundation | Clinical Trials | Our Research Approach CF Foundation Awards Up to $4.7M to EnBiotix Inc. to Develop Inhaled Antibiotic to Treat Pseudomonas

The Cystic Fibrosis Foundation awarded up to $4.7 million to EnBiotix Inc. to study the potential use of inhaled colistin as an additional option to treat Pseudomonas infections in people with cystic fibrosis who are not responding to current treatments.

| 2 min read
About the CF Foundation | Clinical Trials | Our Research Approach CF Foundation Awards Up to $5 Million to BiomX for Potential Phage Therapy

Study reaffirms the Foundation’s commitment to advance solutions to the growing challenge of antibiotic resistance

| 4 min read
Infections CF Foundation Invests $3.5 Million in Pulmocide for Development of Novel Antifungal Treatment for Lung Transplant Recipients

The treatment has the potential to prevent Aspergillus fungal infections in people who have had a lung transplant.

| 4 min read
Research Cystic Fibrosis Foundation Strikes First-of-Its-Kind Deal With Pioneering Medicines, a Flagship Pioneering Initiative

Foundation to fund up to $110 million for collaboration to accelerate the development of genetic therapies for CF

| 4 min read
Research | About the CF Foundation | Our Research Approach CF Foundation Awards Contract to Life Edit Therapeutics to Explore Gene Editing Technology in CF

Today, the Cystic Fibrosis Foundation announced that it has awarded up to $400,000 to Life Edit Therapeutics Inc. to explore the application of their unique gene editing technology in CF.

| 3 min read
Research | About the CF Foundation CF Foundation Commits up to $14 Million in Funding to Expand Research Agreement With Synspira Therapeutics

New funding will support clinical development of two novel therapies to address complications of cystic fibrosis

| 3 min read
Coronavirus (COVID-19) | Our Research Approach First Global Study of COVID-19 in Children With Cystic Fibrosis Reports Reassuring Outcomes

The Cystic Fibrosis Registry Global Harmonization Group, including the Cystic Fibrosis Foundation, published findings from the first global study on the impact of COVID-19 on children with cystic fibrosis in the Journal of Cystic Fibrosis.

| 4 min read